HELEN CUMPTON: Open Payments
NPI 1811178221 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 12 payments from 8 companies in 2025. Trend: 2023 $17 · 2024 $15 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $61 |
| Alkermes, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: HETLIOZ, ARISTADA, VRAYLAR, Auvelity, JOURNAVX, AUSTEDO XR, FANAPT, CAPLYTA.
Industry payments across KY — which companies pay providers there.
